AMICUS THERAPEUTICS INC (FOLD) is a publicly traded company in the Unknown sector. Across all available filings, 28 corporate insiders have executed 1036 transactions totaling $141.2M, demonstrating a bearish sentiment with -$54.6M in net insider flow. The most recent transaction on Jan 20, 2026 involved a transaction of 75,000 shares valued at $0.
No significant insider buying has been recorded for FOLD in the recent period.
No significant insider selling has been recorded for FOLD in the recent period.
Based on recent SEC filings, insider sentiment for FOLD is bearish with an Insider Alignment Score of 31/100 and a net flow of -$54.6M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at AMICUS THERAPEUTICS INC (FOLD) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 28 insiders are actively trading FOLD stock, having executed 1036 transactions in the past 90 days. The most active insider is John F. Crowley (Executive), who has made 245 transactions totaling $78.7M.
Get notified when executives and directors at FOLD file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 20, 2026 | L. Campbell Bradley | Executive | Option Exercise | 75,000 | $N/A | $0 | |
| Jan 20, 2026 | L. Campbell Bradley | Executive | Sale | 75,000 | $14.31 | $1.1M | Large |
| Jan 20, 2026 | L. Campbell Bradley | Executive | Option Exercise | 75,000 | $6.10 | $457.5K | |
| Jan 3, 2026 | Michael Clark David | Chief People Officer | Payment | 18,498 | $14.27 | $264.0K | |
| Jan 3, 2026 | Prout Samantha | Chief Accounting Officer | Payment | 12,240 | $14.27 | $174.7K | |
| Jan 3, 2026 | Castelli Jeff | Chief Development Officer | Payment | 23,102 | $14.27 | $329.7K | |
| Jan 3, 2026 | Rosenberg Ellen | Chief Legal Officer | Payment | 29,683 | $14.27 | $423.6K | |
| Jan 2, 2026 | Michael Clark David | Chief People Officer | Payment | 5,381 | $14.27 | $76.8K | |
| Jan 2, 2026 | Prout Samantha | Chief Accounting Officer | Payment | 3,443 | $14.27 | $49.1K | |
| Jan 2, 2026 | Castelli Jeff | Chief Development Officer | Payment | 6,905 | $14.27 | $98.5K | |
| Jan 2, 2026 | Rosenberg Ellen | Chief Legal Officer | Payment | 13,426 | $14.27 | $191.6K | |
| Dec 26, 2025 | N.r. Harford Simon | Executive | Payment | 71,303 | $14.25 | $1.0M | Large |
| Dec 26, 2025 | L. Campbell Bradley | Executive | Payment | 108,602 | $14.25 | $1.5M | Large |
| Dec 26, 2025 | N.r. Harford Simon | Chief Financial Officer | Payment | 71,303 | $14.25 | $1.0M | C-SuiteLarge |
| Dec 26, 2025 | L. Campbell Bradley | Executive | Payment | 108,602 | $14.25 | $1.5M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 335 | $97.9M | 44.4% |
Purchase(P) | 50 | $43.3M | 19.6% |
Exercise(M) | 262 | $41.5M | 18.8% |
Payment(F) | 191 | $38.1M | 17.2% |
Award(A) | 193 | $33.0K | 0.0% |
Gift(G) | 4 | $0 | 0.0% |
Disposition(D) | 1 | $0 | 0.0% |
Insider selling pressure at AMICUS THERAPEUTICS INC has increased, with 28 insiders executing 1036 transactions across all time. Total sales of $97.9M significantly outpace purchases of $43.3M, resulting in a net outflow of $54.6M. This selling activity appears largely discretionary, which may warrant closer attention from investors.